期刊文献+

结直肠癌患者淋巴结清扫对手术疗效的影响 被引量:2

The effect of colorectal cancer patients surgery with lymph node dissection
下载PDF
导出
摘要 目的研究淋巴结清扫对结直肠癌术后疗效的影响。方法 2009年4月至2014年4月间来本院就诊的结直肠癌患者96例,均无其他严重并发症。其中结肠癌46例,直肠癌50例。对所有患者的结直肠癌进行微创手术切除,根据患者具体情况、征求患者及家属意见的情况下决定是否对患者进行淋巴结清扫,并分为三组,每组32例。第1组是在手术中对淋巴结不进行清扫的患者,第2组是手术中清扫淋巴结为6枚以下的患者,第3组是手术中清扫淋巴结超过6枚以上的患者。制作患者手术情况调查表,对各组患者的手术时间,术中出血量,出院时间,术后1年、3年和5年复发转移情况进行统计。结果三组患者的手术时间和住院时间差异无统计学意义(P>0.05);术中出血量随着清扫淋巴结的增加也有所增加,三组患者间术中出血量比较差异显著(P<0.001);并发症以清扫淋巴结最多的第3组最多,三组患者的术后并发症比较差异显著(P<0.05),三组患者的1年、3年和5年复发转移率比较差异显著(P<0.05)。结论淋巴结清扫有利于控制结直肠癌术后复发和转移。 Objective To study the effect on lymph node dissection in colorectal cancer after curative effect.Methods Between April 2009 to April 2014,96 patients with colorectal cancer were included in this study.Which including 46 cases of colon cancer and 50 cases of rectal cancer. All patients had no other serious complications and were analyzed retrospectively, based on the specific circumstances of the patient, in the case to seek the views of patients and their families to determine whether lymph node dissection for patients divided into three groups, Group 1 was in surgery for patients with lymph node dissection is not performed, the patient cases number of 32 cases, group 2 lymph node dissection surgery in patients 6 below, the first three groups of lymph node dissection surgery in patients over more than six. For all patients with colorectal cancer minimally invasive surgery, and the second group and the third group of patients with lymph node dissection. Production surgery patients questionnaire, for each group of patients operative time, blood loss, hospital time, after 1 year, 3 years and 5 years relapse metastasis statistics. Results The number of cases among the three groups of patients, gender,degree of differentiation of colorectal cancer formation and composition of the same TNM stage, male patients than female patients, male patients of 54 cases, 42 cases of female patients. All patients with colorectal cancer patients up to the degree of differentiation, for 81 cases. The operative time and hospital stay of three groups of patients,although slightly different, but the differences among the three groups was not significant(P 〉0.05), while the blood loss with increase in the lymph nodes also increased, the difference between the three groups of patients the blood loss was significantly(P 〈0.001). Complications in lymph nodes up to a maximum of the first three groups,three groups of postoperative complications in patients with differences significant(P =0.05), but the first three groups of patients a year, the lowest rate of recurrence within 3 years and 5 years, and other differences between the two groups of patients was significantly(P 〈0.05), Conclusion Lymph node dissection help control the situation in colorectal cancer recurrence and metastasis.
作者 邹华
机构地区 阜宁县中医院
出处 《结直肠肛门外科》 2015年第5期354-356,共3页 Journal of Colorectal & Anal Surgery
关键词 结直肠癌 淋巴结清扫 复发 Colorectal Cancer Lymph node Dissection
  • 相关文献

参考文献5

  • 1景阳,孙立波,舒振波,李永超,丁大勇,张惠茅,薄丽华.术前CT三维重建血管密度对结直肠癌淋巴结转移和远处转移的预测价值[J].中华胃肠外科杂志,2013,16(5):448-450. 被引量:6
  • 2Lambregts DM, Beets GL, Maas M,et al. Accuracy of gad- ofosveset-enhanced MRI for nodal staging and restaging in rectal canner [J].Ann Surg,2011,253 (3) : 539 - 545.
  • 3王福龙,万德森,卢震海,方淯靖,李力人,陈功,伍小军,丁培荣,孔令亨,林俊忠,潘志忠.T1和T2期结直肠癌淋巴结转移与相关分子标记物表达的关系[J].中华肿瘤杂志,2013,35(4):277-281. 被引量:9
  • 4Kuang RG, Wu HX, Hao GX, et al. Expression and signif- icance of IGF-2,PCNA,MMP-7,and α-actin in gastric carcinoma with Lauren classification [J]. Turk J Gastroen- terol, 2013, 24(2) : 99-108.
  • 5Shibutani M, Maeda K, Nagahara H, et al. A high pre- operative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal Cancer[J]. Anticancer Res, 2013, 33(8):3291-3294.

二级参考文献42

  • 1Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet, 2010, 375:1030-1047.
  • 2van der Pas MH, Meijer S, Hoekstra OS, et al. Sentinel-lymph- node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol, 2011, 12:540-550.
  • 3AI-Mulla F, Hagan S, Behbehani AI, et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol, 2006, 24:5672-5679.
  • 4Su JL, Yen CJ, Chen PS, et al. The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer, 2007, 96:541-545.
  • 5Theodoropoulos GE, Karafoka E, Papailiou JG, et al. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up. Anticancer Res, 2009, 29: 785-791.
  • 6Kavanagh DO, Chambers G, O'Grady L, et al. ls overexpression of HER-2 a predictor of prognosis in colorectal cancer.'?. BMC Cancer, 2009, 9 : 1.
  • 7Zhang C, Hao L, Wang L, et al. Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer. BMC Cancer, 2010, 10:184.
  • 8Wolpin BM, Meyerhardt JA, Chan AT, et al. Insulin, the insulin- like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol, 2009, 27:176-185.
  • 9Minoo P, Zlobec I, Baker K, et aL Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. Am J Clin Pathol, 2007, 127: 820-827.
  • 10Chu D, Zhao Z, Zhou Y, et al. Matrix metallopmteinase-9 is associated with relapse and prognosis of patients with colorectal cancer. Ann Surg Oncol, 2012, 19:318-325.

共引文献12

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部